{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:55:02Z","timestamp":1775019302123,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12020-020-02459-2","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T12:02:39Z","timestamp":1600948959000},"page":"498-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Metformin downregulates miR223 expression in insulin-resistant 3T3L1 cells and human diabetic adipose tissue"],"prefix":"10.1007","volume":"70","author":[{"given":"Yousof","family":"Naghiaee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Didehdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Pourrajab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Rahmanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeime","family":"Heiranizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azra","family":"Mohiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Mohiti-Ardakani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"issue":"3","key":"2459_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4239\/wjd.v1.i3.68","volume":"1","author":"V Saini","year":"2010","unstructured":"V. Saini, Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J. Diabetes 1(3), 68\u201375 (2010)","journal-title":"World J. Diabetes"},{"key":"2459_CR2","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1128\/MCB.16.6.3074","volume":"16","author":"T Yamauchi","year":"1996","unstructured":"T. Yamauchi, K. Tobe, H. Tamemoto, K. Ueki, Y. Kaburagi, R. Yamamoto-Honda et al. Insulin signaling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol. Cell Biol. 16, 3074\u20133084 (1996)","journal-title":"Mol. Cell Biol."},{"key":"2459_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/372186a0","volume":"372","author":"E Araki","year":"1994","unstructured":"E. Araki, M. Lipes, M.E. Patti, J.C. Br\u00fcning, B. Haag, R.S. Johnson et al. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature 372, 186\u2013190 (1994)","journal-title":"Nature"},{"issue":"2","key":"2459_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12038-007-0038-8","volume":"32","author":"S Bhattacharya","year":"2007","unstructured":"S. Bhattacharya, DeyD, S.S. Roy, Molecular mechanism of insulin resistance. J. Biosci. 32(2), 405\u2013413 (2007)","journal-title":"J. Biosci."},{"issue":"5","key":"2459_CR5","first-page":"57","volume":"18","author":"M Honardoost","year":"2014","unstructured":"M. Honardoost, E. Arefian, Molecular mechanism of insulin resistance. JQUMS 18(5), 57\u201364 (2014)","journal-title":"JQUMS"},{"key":"2459_CR6","doi-asserted-by":"publisher","first-page":"1577532","DOI":"10.1080\/23311932.2019.1577532","volume":"5","author":"AJ Mohiti","year":"2019","unstructured":"A.J. Mohiti, A.A. Mohiti, M. Rahimifard, M. Momtaz, Curcumin increases insulin sensitivity in C2C12muscle cells via AKT and AMPK signaling pathways. Cogent Food Agric. 5, 1577532 (2019)","journal-title":"Cogent Food Agric."},{"key":"2459_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/bj3330471","volume":"333","author":"PR Shepherd","year":"1998","unstructured":"P.R. Shepherd, D.J. Withers, K. Siddle, Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem. J. 333, 471\u2013490 (1998)","journal-title":"Biochem. J."},{"key":"2459_CR8","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1210\/en.2003-1297","volume":"145","author":"LA Barbour","year":"2004","unstructured":"L.A. Barbour, J. Shao, L. Qiao, W. Leitner, M. Anderson, J.E. Friedman et al. Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle. Endocrinology 145, 1144\u20131150 (2004)","journal-title":"Endocrinology"},{"key":"2459_CR9","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.2337\/diabetes.54.8.2351","volume":"54","author":"GK Bandyopadhyay","year":"2005","unstructured":"G.K. Bandyopadhyay, J.G. Yu, J. Ofrecio, J.M. Olefsky, Increased p85\/55\/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54, 2351\u20132359 (2005)","journal-title":"Diabetes"},{"key":"2459_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1172\/JCI5001","volume":"103","author":"A Dresner","year":"1999","unstructured":"A. Dresner, D. Laurent, M. Marcucci, M.E. Griffin, S. Dufour, G.W. Cline et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Investig. 103, 253\u2013259 (1999)","journal-title":"J. Clin. Investig."},{"issue":"50","key":"2459_CR11","doi-asserted-by":"publisher","first-page":"43229","DOI":"10.1074\/jbc.M111.306621","volume":"286","author":"D Balamatsias","year":"2011","unstructured":"D. Balamatsias, A.M. Kong, J.E. Waters, A. Sriratana, R. Gurung, C.G. Bailey et al. Identification of P-Rex1 as a novel Rac1-guanine nucleotide exchange factor (GEF)that promotes actin remodeling and GLUT4protein trafficking in adipocytes. J. Biol. Chem. 286(50), 43229\u201343240 (2011)","journal-title":"J. Biol. Chem."},{"key":"2459_CR12","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1073\/pnas.061035098","volume":"98","author":"LF Michael","year":"2001","unstructured":"L.F. Michael, Z. Wu, R.B. Cheatham, P. Puigserver, G. Adelmant, J.J. Lehman et al. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc. Natl Acad. Sci. USA 98, 3820\u20133825 (2001)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2459_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2337\/diacare.13.3.228","volume":"13","author":"A Klip","year":"1990","unstructured":"A. Klip, M. Paguet, Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care. 13, 228\u2013243 (1990)","journal-title":"Diabetes Care."},{"key":"2459_CR14","first-page":"37530","volume":"287","author":"RW Schwenk","year":"2012","unstructured":"R.W. Schwenk, Y. Angin, L.K. Steinbusch, E. Dirkx, N. Hoebers, W.A. Coumans et al. Overexpression of vesicle-associatedmembrane protein (VAMP) 3, but notVAMP2, protects glucose transporter(GLUT) 4 protein translocation in an in vitromodel of cardiac insulin resistance. J. BiolChem 287, 37530\u201337539 (2012)","journal-title":"J. BiolChem"},{"issue":"12","key":"2459_CR15","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.1074\/jbc.272.12.7759","volume":"272","author":"MJ Thomson","year":"1997","unstructured":"M.J. Thomson, M.G. Williams, S.C. Frost, Development of insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 272(12), 7759\u20137764 (1997)","journal-title":"J. Biol. Chem."},{"issue":"4","key":"2459_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12291-012-0214-y","volume":"27","author":"A Absalan","year":"2012","unstructured":"A. Absalan, A.J. Mohiti, H. Hadinedoushan, M.A. Khalili, Hydro-alcoholic cinnamon extract, enhances glucose transporter isotype-4 translocation from intracellular compartments into the cytoplasmic membrane of C2C12 myotubes. Indian J. Clin. Biochem. 27(4), 351\u2013356 (2012)","journal-title":"Indian J. Clin. Biochem."},{"key":"2459_CR17","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","volume":"51","author":"SI Itani","year":"2002","unstructured":"S.I. Itani, N. Ruderman, F. Schmieder, G. Boden, Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51, 2005\u20132011 (2002)","journal-title":"Diabetes"},{"key":"2459_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2337\/diabetes.51.1.7","volume":"51","author":"JD McGarry","year":"2001","unstructured":"J.D. McGarry, Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51, 7\u201318 (2001)","journal-title":"Diabetes"},{"key":"2459_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"AR Saltiel","year":"2001","unstructured":"A.R. Saltiel, C.R. Khan, Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799\u2013806 (2001)","journal-title":"Nature"},{"key":"2459_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/JCI10842","volume":"106","author":"BB Kahn","year":"2000","unstructured":"B.B. Kahn, J.S. Flier, Obesity and insulin resistance. J. Clin. Investig. 106, 473\u2013481 (2000)","journal-title":"J. Clin. Investig."},{"key":"2459_CR21","doi-asserted-by":"crossref","unstructured":"S. A. Smith, Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones. Scientific Affairs, Diabetes. 85, 1219\u20131231 (2003)","DOI":"10.1016\/j.biochi.2003.10.010"},{"key":"2459_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1043-2760(03)00024-9","volume":"14","author":"P Arner","year":"2003","unstructured":"P. Arner, The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol. Metab. 14, 137\u2013145 (2003)","journal-title":"Trends Endocrinol. Metab."},{"key":"2459_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.phrs.2013.06.005","volume":"75","author":"Y Mao","year":"2013","unstructured":"Y. Mao, R. Mohan, S. Zhang, X. Tang, MicroRNAs as pharmacological targets in diabetes. Pharmacol. Res. 75, 37\u201347 (2013)","journal-title":"Pharmacol. Res."},{"key":"2459_CR24","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-13-0544","volume":"222","author":"H Chen","year":"2014","unstructured":"H. Chen, H.Y. Lan, D.H. Roukos, W.C. Cho, Application of microRNAs in diabetes mellitus. Endocrinology 222, R1\u2013R10 (2014)","journal-title":"Endocrinology"},{"key":"2459_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/jomb-2018-0009","volume":"37","author":"IH Demirsoy","year":"2018","unstructured":"I.H. Demirsoy, D.Y. Ertural, E. Balci, U. \u00c7\u0131nk\u0131r, K. Sezer, N. Aras, profiles of circulating mirnas following metformin treatment inpatients with type 2 diabetes. J. Med. Biochem. 37, 1\u20137 (2018)","journal-title":"J. Med. Biochem."},{"key":"2459_CR26","first-page":"8","volume":"484696","author":"MD Williams","year":"2012","unstructured":"M.D. Williams, G.M. Mitchell, MicroRNAs in insulin resistance and obesity. Diabetes Res. 484696, 8 (2012)","journal-title":"Diabetes Res."},{"issue":"1","key":"2459_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ijo.2015.170","volume":"40","author":"JA Deiuliis","year":"2015","unstructured":"J.A. Deiuliis, MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics. Int. J. Obes. 40(1), 88\u2013101 (2015)","journal-title":"Int. J. Obes."},{"key":"2459_CR28","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s00125-015-3510-2","volume":"58","author":"H Zhu","year":"2015","unstructured":"H. Zhu, S.W. Leung, Identification of microRNA biomarkers in type 2 diabetes:a meta-analysis of controlled profiling studies. Diabetologia 58, 900\u2013911 (2015)","journal-title":"Diabetologia"},{"key":"2459_CR29","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/j.1440-1681.2009.05207.x","volume":"36","author":"HY Ling","year":"2009","unstructured":"H.Y. Ling, H.S. Ou, S.D. Feng, X.Y. Zhang, Q.H. Tuo, L.X. Chen et al. Changes in microrna (mir) profile and effects of mir-320 in insulin-resistant 3t3-l1 adipocytes. Clin. Exp. Pharmacol. Physiol. 36, e32\u2013e9 (2009)","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2459_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12010-014-1014-z","volume":"174","author":"M Honardoost","year":"2014","unstructured":"M. Honardoost, M.R. Sarookhani, E. Arefian, M. Soleimani, Insulin resistance associated genes and miRNAs. Appl. Biochem. Biotechnol. 174, 63\u201380 (2014)","journal-title":"Appl. Biochem. Biotechnol."},{"key":"2459_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.gene.2013.10.011","volume":"533","author":"G Song","year":"2014","unstructured":"G. Song, G. Xu, C. Ji, C. Shi, Y. Shen, L. Chen et al. The role of microRNA-26b in human adipocyte differentiation and proliferation. Gene 533, 481\u2013487 (2014)","journal-title":"Gene"},{"issue":"09","key":"2459_CR32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/s-0032-1311644","volume":"120","author":"HY Ling","year":"2012","unstructured":"H.Y. Ling, B. Hu, X.B. Hu, J. Zhong, S.D. Feng, L. Qin et al. MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue. Exp. Clin. Endocrinol. Diabetes 120(09), 553\u2013559 (2012)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"2459_CR33","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/39335","volume":"389","author":"KT Uysal","year":"1997","unstructured":"K.T. Uysal, S.M. Wiesbrock, M.W. Marino, G.S. Hotamisligil, Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389, 610\u2013614 (1997)","journal-title":"Nature"},{"key":"2459_CR34","doi-asserted-by":"publisher","first-page":"943659","DOI":"10.1155\/2015\/943659","volume":"2015","author":"TY Chuang","year":"2015","unstructured":"T.Y. Chuang, H.L. Wu, C.C. Chen, G.M. Gamboa, L.C. Layman, M.P. Diamond et al. MicroRNA-223 expression is upregulated in insulin resistant human adipose tissue. J. Diabetes Res. 2015, 943659 (2015)","journal-title":"J. Diabetes Res."},{"issue":"11","key":"2459_CR35","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1210\/me.2007-0167","volume":"21","author":"A He","year":"2007","unstructured":"A. He, L. Zhu, N. Gupta, Y. Chang, F. Fang, Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 21(11), 2785\u20132794 (2007)","journal-title":"Mol. Endocrinol."},{"key":"2459_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ab.2012.03.005","volume":"425","author":"K Zebisch","year":"2012","unstructured":"K. Zebisch, V. Voigt, M. Wabitsch, M. Brandsch, Protocol for effective differentiation of 3T3-L1 cells to adipocytes. Anal. Biochem. 425, 88\u201390 (2012)","journal-title":"Anal. Biochem."},{"key":"2459_CR37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1042\/bj2700331","volume":"270","author":"M Weiland","year":"1990","unstructured":"M. Weiland, A. Schurmann, W.E. Schmidt, H.G. Joost, Development of the hormone-sensitive glucose transport activity indifferentiating 3T3-L1 murine fibroblasts. Biochem. J. 270, 331\u2013336 (1990)","journal-title":"Biochem. J."},{"key":"2459_CR38","doi-asserted-by":"crossref","unstructured":"D.Z. Malekpour, M. Nourbakhsh, Y. Naghiaee, R. Sharifi, A.J. Mohiti, Metformin reducesfibrosis factors in insulin resistant and hypertrophied adipocyte via integrin\/ERK, collagenVI, apoptosis, and necrosis reduction. Life Sci. 233, 116682 (2019)","DOI":"10.1016\/j.lfs.2019.116682"},{"issue":"10","key":"2459_CR39","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/ijo.2015.95","volume":"39","author":"G Xu","year":"2015","unstructured":"G. Xu, C. Ji, G. Song, C. Zhao, C. Shi, L. Song et al. MiR-26b modulates insulin sensitivity in adipocytes by interrupting the PTEN\/PI3K\/AKT pathway. Int. J. Obes. 39(10), 1523\u20131530 (2015)","journal-title":"Int. J. Obes."},{"key":"2459_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12079-012-0188-9","volume":"7","author":"D Vishwanath","year":"2013","unstructured":"D. Vishwanath, H. Srinivasan, M.S. Patil, S. Seetarama, S.K. Agrawal, M.N. Dixit et al. Novel method to differentiate 3T3L1 cells in vitro to producehighly sensitive adipocytes for a GLUT4 mediated glucoseuptake using fluorescent glucose analog. J. Cell Commun. Signal. 7, 129\u2013140 (2013)","journal-title":"J. Cell Commun. Signal."},{"key":"2459_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ab.2006.12.016","volume":"362","author":"A Mehra","year":"2007","unstructured":"A. Mehra, I. Macdonald, T.S. Pillay, Variability in 3T3-L1 adipocyte differentiation depending on cell culture dish. Anal. Biochem. 362, 281\u2013283 (2007)","journal-title":"Anal. Biochem."},{"key":"2459_CR42","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2337\/diabetes.49.6.981","volume":"49","author":"BA Nelson","year":"2000","unstructured":"B.A. Nelson, K.A. Robinson, M.G. Buse, High glucose and glucosamine induce insulin resistance via different mechanisms in3T3-L1 adipocytes. Diabetes 49, 981\u2013991 (2000)","journal-title":"Diabetes"},{"key":"2459_CR43","doi-asserted-by":"crossref","unstructured":"D.Z. Malekpour, A.J. Mohiti, M. Nourbakhsh, S. Teimourian, Y. Naghiaee, F. Jafary, Gene expression profile evaluation of integrins in 3T3-L1 cells differentiated toadipocyte, insulin resistant and hypertrophied cells. Genes. 710, 0378\u20131119 (2019)","DOI":"10.1016\/j.gene.2019.06.019"},{"key":"2459_CR44","doi-asserted-by":"publisher","unstructured":"Y. Naghiaee, R. Didehdar, D.Z. Malekpour, F. Pourrajab, A.J. Mohiti, Descending expression of miR-320 in insulin resistant adipocytes treated with ascending concentrations of metformin. Biochem. Genet. (2020). https:\/\/doi.org\/10.1007\/s10528-020-09964-z","DOI":"10.1007\/s10528-020-09964-z"},{"key":"2459_CR45","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1039\/C0MB00089B","volume":"7","author":"DW Jung","year":"2011","unstructured":"D.W. Jung, H.H. Ha, X. Zheng, Y.T. Chang, D.R. Williams, Novel use of fluorescent glucose analogues to identify a new classof triazine-based insulin mimetics possessing useful secondary effects. Mol. Biosyst. 7, 346\u2013358 (2011)","journal-title":"Mol. Biosyst."},{"key":"2459_CR46","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.amsu.2018.11.005","volume":"36","author":"T Fontes","year":"2018","unstructured":"T. Fontes, I. Brandao, R. Negrao, M.J. Martins, R. Monteiro, Autologous fat grafting: harvesting techniques. Ann. Med. Surg. 36, 212\u2013218 (2018)","journal-title":"Ann. Med. Surg."},{"issue":"4","key":"2459_CR47","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/PRS.0000000000001590","volume":"136","author":"AL Strong","year":"2015","unstructured":"A.L. Strong, P.S. Cederna, J.P. Rubin, S.R. Coleman, B. Levi, The current state of fat grafting: a review of harvesting, processing, and injection techniques. Plast. Reconstr. Surg. 136(4), 897\u2013912 (2015)","journal-title":"Plast. Reconstr. Surg."},{"key":"2459_CR48","first-page":"215","volume":"806","author":"T Skurk","year":"2012","unstructured":"T. Skurk, H. Hauner, Primary culture of human adipocyte precursor cells: expansion and differentiation. Mol. Biol. 806, 215\u2013226 (2012)","journal-title":"Mol. Biol."},{"key":"2459_CR49","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-1-61779-367-7_14","volume":"806","author":"KA Carswell","year":"2012","unstructured":"K.A. Carswell, M.J. Lee, S.K. Fried, Culture of isolated human adipocytes and isolated adipose tissue. Methods Mol. Biol. 806, 203\u2013214 (2012)","journal-title":"Methods Mol. Biol."},{"key":"2459_CR50","doi-asserted-by":"crossref","unstructured":"X. Ge, S.C. Leow, D. Sathiakumar, W. St\u00fcnkel, A. Shabbir, J. Bok Yan So et al. Isolation and culture of human adipose-derived stem cells from subcutaneous and visceral white adipose tissue compartments. Bio-protocol. 6(22), (2016)","DOI":"10.21769\/BioProtoc.2027"},{"key":"2459_CR51","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression datausing real-time quantitative PCR and the 2\u2013\u0394\u0394CT method. Methods 25, 402\u2013408 (2001)","journal-title":"Methods"},{"issue":"6","key":"2459_CR52","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"T.D. Schmittgen, K.J. Livack, Analysing real time PCR data by the comparative CT method. Nat. Protoc. 3(6), 1101\u20131108 (2008)","journal-title":"Nat. Protoc."},{"key":"2459_CR53","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.metabol.2015.05.013","volume":"64","author":"E Flowers","year":"2015","unstructured":"E. Flowers, B.E. Aouizerat, F. Abbasi, C. Lamendola, K.M. Grove, Y. Fukuoka et al. Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: Moving towards precision health for diabetes prevention. Metab. Clin. Exp. 64, 1051\u20131059 (2015)","journal-title":"Metab. Clin. Exp."},{"issue":"24(4)","key":"2459_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1089\/scd.2014.0331","volume":"15","author":"D Hamam","year":"2015","unstructured":"D. Hamam, M. Kassem, A. Aldahmash, N.M. Alajez, microRNAs as regulators of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev. 15(24(4)), 417\u2013425 (2015)","journal-title":"Stem Cells Dev."},{"key":"2459_CR55","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbrc.2012.08.082","volume":"426","author":"A Bagge","year":"2012","unstructured":"A. Bagge, T.R. Clausen, S. Larsen, M. Ladefoged, M.W. Rosenstierne, L. Larsen et al. MicroRNA-29a is up-regulated in beta-cells by glucose and decreasesglucose-stimulated insulin secretion. Biochem. Biophys. Res. Commun. 426, 266\u2013272 (2012)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2459_CR56","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.2337\/db12-0963","volume":"62","author":"YH Chen","year":"2013","unstructured":"Y.H. Chen, S. Heneidi, J.M. Lee, L.C. Layman, D.W. Stepp, G.M. Gamboa et al. MiRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patientsand women with insulin resistance. Diabetes 62, 2278\u20132286 (2013)","journal-title":"Diabetes"},{"key":"2459_CR57","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/cvr\/cvq010","volume":"86","author":"H Lu","year":"2010","unstructured":"H. Lu, R.J. Buchan, S.A. Cook, MicroRNA-223 regulates Glut4 expressionand cardiomyocyte glucose metabolism. Cardiovasc. Res. 86, 410\u2013420 (2010)","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"2459_CR58","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1677\/joe.0.1670107","volume":"167","author":"J Shao","year":"2000","unstructured":"J. Shao, H. Yamashita, L. Qiao, J.E. Friedman, Decreased Akt kinase activity and insulin resistance in C57BL\/KsJ-Leprdb\/db mice. J. Endocrinol. 167(1), 107\u2013115 (2000)","journal-title":"J. Endocrinol."},{"issue":"5","key":"2459_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216665","volume":"14","author":"Y Xing","year":"2019","unstructured":"Y. Xing, J. Zhang, H. Wei, H. Zhang, Y. Guan, X. Wang et al. Reduction of the PI3K\/Akt related signaling activities in skeletal muscle tissues involves insulin resistance in intrauterine growth restriction rats with catch-up growth. Plos ONE 14(5), e0216665 (2019)","journal-title":"Plos ONE"},{"issue":"8","key":"2459_CR60","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2337\/diab.47.8.1281","volume":"47","author":"A Krook","year":"1998","unstructured":"A. Krook, R.A. Roth, X.J. Jiang, J.R. Zierath, H. Wallberg-Henriksson, Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47(8), 1281\u20131286 (1998)","journal-title":"Diabetes"},{"key":"2459_CR61","doi-asserted-by":"publisher","first-page":"818945","DOI":"10.1155\/2009\/818945","volume":"2009","author":"A Leonardini","year":"2009","unstructured":"A. Leonardini, L. Laviola, S. Perrini, A. Natalicchio, F. Giorgino, Cross-talk between PPARgamma and insulin signaling and modulation of insulin sensitivity. PPAR Res. 2009, 818945 (2009)","journal-title":"PPAR Res."},{"issue":"6","key":"2459_CR62","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","volume":"122","author":"B Viollet","year":"2012","unstructured":"B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, F. Andreelli, Cellular and molecular mechanisms of metformin: an overview. Clin. Sci. (Lond.) 122(6), 253\u2013270 (2012)","journal-title":"Clin. Sci. (Lond.)"},{"issue":"4","key":"2459_CR63","doi-asserted-by":"publisher","first-page":"E907","DOI":"10.1152\/ajpendo.00235.2009","volume":"297","author":"MF Riera","year":"2009","unstructured":"M.F. Riera, M.N. Galardo, E.H. Pellizzari, S.B. Meroni, S.B. Cigorraga, Molecular mechanisms involved in Sertoli cell adaptation to glucose deprivation. Am. J. Physiol. Endocrinol. Metab. 297(4), E907\u2013E914 (2009)","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"2459_CR64","first-page":"1105","volume":"40","author":"Y Tian","year":"2012","unstructured":"Y. Tian, Y. Nan, L. Han, A. Zhang, G. Wang, Z. Jia et al. MicroRNA miR-451 downregulates the PI3K\/AKT pathway through CAB39 in human glioma. Int J. Oncol. 40(4), 1105\u20131112 (2012)","journal-title":"Int J. Oncol."},{"issue":"1","key":"2459_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1750-2187-5-1","volume":"5","author":"R Tao","year":"2010","unstructured":"R. Tao, J. Gong, X. Luo, M. Zang, W. Guo, R. Wen et al. AMPK exerts dual regulatory effects on the PI3K pathway. J. Mol. Signal 5(1), 1 (2010)","journal-title":"J. Mol. Signal"},{"key":"2459_CR66","doi-asserted-by":"publisher","first-page":"830501","DOI":"10.1155\/2009\/830501","volume":"2009","author":"A Belfiore","year":"2009","unstructured":"A. Belfiore, GenuaM, R. Malaguarnera, PPAR-\u03b3 agonists and their effects on IGF-I receptor signaling: Implications for cancer. PPAR Res. 2009, 830501 (2009)","journal-title":"PPAR Res."},{"issue":"6","key":"2459_CR67","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jdiacomp.2015.04.012","volume":"29","author":"X Peng","year":"2015","unstructured":"X. Peng, K.W. Cheng, J. Ma, B. Chen, C.T. Ho, C. Lo et al. PPAR\u03b3-PI3K\/AKT-NO signal pathway is involved in cardiomyocyte hypertrophy induced by high glucose and insulin. J. Diabetes Complicat. 29(6), 755\u201360 (2015)","journal-title":"J. Diabetes Complicat."},{"key":"2459_CR68","first-page":"93","volume":"6","author":"A Bruckbauer","year":"2013","unstructured":"A. Bruckbauer, M.B. Zemel, Synergistic effects of metformin, resveratrol,and hydroxymethylbutyrate on insulin sensitivity. Diabetes, Metab. Syndr. Obes. Targets Ther. 6, 93\u2013102 (2013)","journal-title":"Diabetes, Metab. Syndr. Obes. Targets Ther."},{"key":"2459_CR69","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1016\/S1262-3636(03)72785-2","volume":"29","author":"R Giannarelli","year":"2003","unstructured":"R. Giannarelli, M. Aragona, A. Cappelli, S. Del Prato, Reducing insulin resistance with metformin: the evidence today. Diabetes Metab. 29, 6528\u201335 (2003)","journal-title":"Diabetes Metab."},{"issue":"5","key":"2459_CR70","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0015-0282(16)58266-1","volume":"65","author":"O Acbay","year":"1996","unstructured":"O. Acbay, S. Gundogdu, Can metformin reduce insulin resistance in polycysticovarysyndrome. Fertil. Steril. 65(5), 946\u2013949 (1996)","journal-title":"Fertil. Steril."},{"issue":"8","key":"2459_CR71","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Investig. 108(8), 1167\u20131174 (2001)","journal-title":"J. Clin. Investig."},{"issue":"2","key":"2459_CR72","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3803\/EnM.2014.29.2.122","volume":"29","author":"YH Son","year":"2014","unstructured":"Y.H. Son, S. Ka, A.Y. Kim, J.B. Kim, Regulation of adipocyte differentiation via microRNAs. Endocrinol. Metab. 29(2), 122\u2013135 (2014)","journal-title":"Endocrinol. Metab."},{"issue":"4","key":"2459_CR73","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3892\/ijmm.2015.2092","volume":"35","author":"A Katsura","year":"2015","unstructured":"A. Katsura, A. Morishita, H. Iwama, J. Tani, T. Sakamoto, M. Tatsuta et al. MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis. Int J. Mol. Med. 35(4), 877\u2013884 (2015)","journal-title":"Int J. Mol. Med."},{"issue":"6","key":"2459_CR74","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.celrep.2015.04.016","volume":"11","author":"KI Ansari","year":"2015","unstructured":"K.I. Ansari, D. Ogawa, A.K. Rooj, S.E. Lawler, A.M. Krichevsky, M.D. Johnson et al. Glucose-based regulation of miR-451\/AMPK signaling depends on the OCT1 transcription factor. Cell Rep. 11(6), 902\u2013909 (2015)","journal-title":"Cell Rep."},{"issue":"5","key":"2459_CR75","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1096\/fj.201701100R","volume":"32","author":"A Martinez-Sanchez","year":"2018","unstructured":"A. Martinez-Sanchez, M.S. Nguyen-Tu, I. Cebola, A. Yavari, P. Marchetti, L. Piemonti et al. MiR-184 expression is regulated by AMPK in pancreatic islets. FASEB J. 32(5), 2587\u20132600 (2018)","journal-title":"FASEB J."},{"key":"2459_CR76","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","volume":"50","author":"EM Kroh","year":"2010","unstructured":"E.M. Kroh, PR, P. Mitchell, M. Tewari, Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRTPCR). Methods 50, 298\u2013301 (2010)","journal-title":"Methods"},{"key":"2459_CR77","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"D.P. Bartel, MicroRNAs: target recognition and regulatory functions. Cell 136, 215\u2013233 (2009)","journal-title":"Cell"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02459-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02459-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02459-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T11:51:16Z","timestamp":1650541876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02459-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2459"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02459-2","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}